Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations
How Does the Projected Market Size of the Pharma Grade Calcium Sulphate Market Compare to 2025 Levels?
The pharma grade calcium sulphate market size has grown strongly in recent years. It will grow from $0.89 billion in 2024 to $0.96 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing demand for pharmaceutical applications, growing use in medical treatments and surgeries, rising awareness about bone health, advancements in drug delivery systems, and increasing prevalence of bone-related diseases.
The pharma grade calcium sulphate market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing aging population, rise in bone and joint disorders, increasing healthcare spending in emerging economies, increasing use of calcium sulfate in regenerative medicine, and expansion of the pharmaceutical industry. Major trends in the forecast period include shift towards organic and natural sources of calcium sulfate, technological advancements in calcium sulfate synthesis methods, focus on sustainability and eco-friendly manufacturing practices, advancements in controlled-release drug delivery technologies, and advanced drug formulations.
Claim your free report sample now:
What Are the Key Factors Contributing to Pharma Grade Calcium Sulphate Market Growth?
The growing demand for pharmaceuticals is expected to propel the growth of the pharma grade calcium sulphate market going forward. Pharmaceuticals refer to drugs and medications that are developed, manufactured, and used to diagnose, treat, or prevent diseases in humans and animals. The growing demand for pharmaceuticals is primarily driven by the rising prevalence of chronic diseases, as more individuals require long-term medications to manage conditions such as diabetes, cardiovascular disorders, and cancer. Pharma grade calcium sulphate enhances pharmaceutical formulations by serving as a high-purity excipient that ensures consistent tablet hardness, stability, and controlled release of active ingredients. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association, in 2022, North America represented 52.3% of global pharmaceutical sales, while Europe accounted for 22.4%. Therefore, the growing demand for pharmaceuticals is driving the growth of the pharma grade calcium sulphate market.
What Are the Core Segments Shaping the Pharma Grade Calcium Sulphate Market Landscape?
The pharma grade calcium sulphate market covered in this report is segmented –
1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite
2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents
3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution
Subsegments:
1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade
2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate
3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite
What Are the Top Trends Expected to Shape the Pharma Grade Calcium Sulphate Market by 2029?
Major companies operating in the pharma grade calcium sulphate market are focusing on developing innovative products by using synthetic medical-grade bassanite to enhance the purity and consistency of calcium sulphate products. Synthetic medical-grade bassanite, a high-purity, partially dehydrated form of calcium sulphate (CaSO4·0.5H2O), helps produce pharma-grade calcium sulphate by providing a consistent, contaminant-free source that meets strict regulatory standards for use in medical and pharmaceutical applications. For instance, in February 2025, Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, launched Caspro & Bonyx, innovative drug-eluting bone graft products developed using synthetic medical-grade bassanite to ensure high purity, biocompatibility, and controlled drug delivery for advanced orthopedic applications. Caspro is a self-setting, mouldable bone cement made from calcium sulfate hemihydrate reinforced with phosphate ions, ideal for filling bone defects and delivering drugs at the site of implantation for over 21 days. Bonyx consists of osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other medications in liquid form, enabling sustained drug release for more than 30 days. These products represent a significant step forward in localized therapy for bone infections and regeneration, demonstrating how pharma-grade calcium sulfate can be utilized in next-generation biomedical solutions that meet stringent international standards.
Which Players Dominate the Pharma Grade Calcium Sulphate Market Landscape?
Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Honeywell International Inc., Merck KGaA, Solvay S.A., Avantor Inc., MP Biomedicals LLC, Spectrum Chemical Manufacturing Corp., Anhui Sunhere Pharmaceutical Excipients, SRL Chemical, GFS Chemicals Inc., American Elements, Loba Chemie Pvt. Ltd., Annexe Chem, Noah Technologies Corporation, Junsei Chemical Co. Ltd, Nikunj Chemicals, Shiva Inorganics, Huzhou Zhanwang Pharmaceutical Co. Ltd., China Shuanghua Gypsum, Jingmen City Leixin Gypsum
Get the full pharma grade calcium sulphate market report here:
What Are the Regional Insights for the Pharma Grade Calcium Sulphate Market Forecast?
North America was the largest region in the pharma grade calcium sulphate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment